A Study to Evaluate the Process of Eating in Patients with Active Eosinophilic Esophagitis (EoE) compared to inactive Eosinophilic Esophagitis (EoE) and Healthy Participants

Overview

About this study

The purpose of this study is to to evaluate the process of eating in patients with active EoE compared to inactive EoE and controls.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years of age
  • Patients suspected to have Eosinophilic Esophagitis (EoE)
  • Patients being treated for EoE with PPI or a steriod
  • EoE patients that are in remission by having < 22 on the EEsAI questionnaire
  • Controls- patients that do not have EoE or other swallowing issues

Exclusion Criteria:

  • Clinical evidence of infectious process potentially contributing to dysphagia (e.g. candidiasis, CMV, herpes)
  • Other cause of dysphagia identified at endoscopy (e.g. reflux esophagitis, stricture, web, ring, achalasia, esophageal neoplasm)
  • EoE patients that do not eat sandwiches or feel they could not eat a sandwich

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Alexander, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions